ESG

AEON Biopharma hires a seasoned CFO to navigate FDA trials and financial hurdles as it aims to launch its BOTOX biosimilar into a lucrative market.

BETA Technologies will launch electric air services across 10 states, deploying its ALIA aircraft for cargo, medical, and critical logistics missions.

A new report lauds PA's PHARE housing fund for its success, but reveals a staggering 2.5x gap between funding requests and available resources.

Séché Environnement's 2025 results reveal a dual strategy: aggressive international expansion and acquisitions funded by green bonds counter domestic slowdowns.

Ottawa injects over $900M into defence innovation, fueling a new strategy to boost domestic tech, meet NATO commitments, and create high-skill jobs.

A startup using trained dogs and AI to sniff out cancer from breath samples was just named a "Fierce 15" company. Can this technology change screening?

With 8x sales growth and 90% prediction accuracy, AI pioneer QuantHealth is proving that simulating clinical trials can slash pharma's $50B failure rate.

A new partnership is testing if 'brain training' games can boost student performance. But in a field full of hype, can this study deliver real answers?

NOAA's approval of a key application for seabed mining boosts US critical mineral hopes but sparks fierce opposition from scientists and nations fearing ruin.

A new, highly selective drug for Duchenne muscular dystrophy shows potential to be safer and more effective, targeting both muscle and heart decline.

A landmark European approval for Elfabrio allows stable Fabry disease patients to switch to monthly infusions, promising greater freedom and lower healthcare strain.

A $5M US government investment in a Macedonian antimony mine aims to secure Western supply chains, de-risking a potential IPO for Australia's Pela Global.

With a new chairman at the helm, NATSO's 2026 board is set to navigate the complex challenges of EV charging, new regulations, and evolving customer demands.

As Capricor prepares its Q4 earnings call, all eyes are on its DMD drug Deramiocel's FDA path, financial health, and next-gen exosome technology.

Thorne released impressive consumer data for its supplements. But what do these studies really mean for consumers in a crowded, unregulated market?

A Florida golf company is merging to form a U.S. drone firm backed by Eric and Donald Trump Jr., aiming to dominate the defense technology market.

The iconic distillery's latest limited release honors its operations teams, blending innovative wood finishing with a story of human craftsmanship.

A new surgical robot from Beijing's Healinno Tech uses AI and a high-pressure waterjet to treat prostate issues with unprecedented precision and safety.

The Braille Challenge arrives in Kenya, its first African location, aiming to boost literacy for thousands of visually impaired students facing a resource gap.

Healthcare tech firm Marpai secures a massive marketing deal, gaining potential access to 1.5 million employees for its transparent pharmacy benefit platform.